Cargando…
Low-molecular-weight anti-HIV-1 agents targeting HIV-1 capsid proteins
The HIV-1 capsid is a shell that encapsulates viral RNA, and forms a conical structure by assembling oligomers of capsid (CA) proteins. Since the CA proteins are highly conserved among many strains of HIV-1, the inhibition of the CA function could be an appropriate goal for suppression of HIV-1 repl...
Autores principales: | Kobayakawa, Takuya, Yokoyama, Masaru, Tsuji, Kohei, Fujino, Masayuki, Kurakami, Masaki, Onishi, Takato, Boku, Sayaka, Ishii, Takahiro, Miura, Yutaro, Shinohara, Kouki, Kishihara, Yuki, Ohashi, Nami, Kotani, Osamu, Murakami, Tsutomu, Sato, Hironori, Tamamura, Hirokazu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9834766/ https://www.ncbi.nlm.nih.gov/pubmed/36712613 http://dx.doi.org/10.1039/d2ra06837k |
Ejemplares similares
-
Small-Molecule Anti-HIV-1 Agents Based on HIV-1 Capsid Proteins
por: Kobayakawa, Takuya, et al.
Publicado: (2021) -
Discovery and Development of Anti-HIV Therapeutic Agents: Progress Towards Improved HIV Medication
por: Maeda, Kenji, et al.
Publicado: (2019) -
Dimerized fusion inhibitor peptides targeting the HR1–HR2 interaction of SARS-CoV-2
por: Tsuji, Kohei, et al.
Publicado: (2023) -
Benzolactam-related compounds promote apoptosis of HIV-infected human cells via protein kinase C–induced HIV latency reversal
por: Matsuda, Kouki, et al.
Publicado: (2019) -
A Therapeutic Strategy to Combat HIV-1 Latently Infected Cells With a Combination of Latency-Reversing Agents Containing DAG-Lactone PKC Activators
por: Matsuda, Kouki, et al.
Publicado: (2021)